1,3-Asymmetric induction in dianionic allylation reactions of amino acid derivatives-synthesis of functionally useful enantiopure glutamates, pipecolates and pyroglutamates

Tetrahedron Letters

Volumn 39, Issue 33, 1998, Pages 5887-5890

  Hanessian, Stephen ^a   Margarita, Roberto ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Allylation; Amino acids and derivatives; Asymmetric induction; Peptide analogs mimetics

Indexed keywords

AMINO ACID DERIVATIVE; GLUTAMIC ACID; PIPECOLIC ACID; PYROGLUTAMIC ACID;

ARTICLE; ENANTIOMER; HYDROLYSIS; HYDROXYLATION; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 0032514576     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(98)00900-9     Document Type: Article

References (53)

1. [1] a) Hollmann, M.; Heinemann, S. Annu. Rev. Neurosci. 1994, 17, 31;
2. b) Nakanishi, S. Science 1992, 258, 597;
3. c) Collingridge, G.L.; Lester, R.A.J. Pharmacol. Rev. 1989, 40, 143;
4. [2] a) Olney, J. W. Annu. Rev. Pharmacol. Toxicol. 1990, 30, 47;
5. b) Choi, D. W. Annu. Rev. Pharmacol. Toxicol. 1990, 30, 171;
6. [3] a) Tückmantel, W.; Kozikowski, A.P.; Wang, S.; Pshenichkin, S.; Wroblewski, J.T. Bioorg. & Med. Chem. Lett. 1997, 7, 601;
7. b) Shimamoto, K.; Shigeri, Y.; Nakajima, T.; Yumoto, N.; Yoshikawa, S.; Ohfune, Y. Bioorg. & Med. Chem. Lett. 1996 6, 2381;
8. c) Knöpfel, T.; Kuhn, R.; Allgeier, H. J. Med. Chem. 1995, 38, 1417;
9. d) Chamberlin, R.; Bridges R. in "Drug Design for Neuroscience" Kozikowski, A. P. Ed.; Raven Press, Ltd.: New York, 1993; p. 231;
10. e) Pin, J.-P.; Duvoisin, R. Neuropharmacology 1995, 34, 1;
11. f) Kroona, H.B.; Peterson, N.L.; Koerner, J.F.; Johnson, R.L. J. Med. Chem. 1991, 34, 1692.
12. [4] a) Lehmann, M. S.; Nupes, A.C. Acta Crystallog. 1980, B36, 1221;
13. b) Ham, N. S. in "Molecular and Quantum Pharmacology", Bergmann, E.; Pullman, B. Eds.; D. Reidel Publishing, 1974, p. 261.
14. [5] a) Omstein, P. L; Bleish, T. J.; Arnold, M.B.; Wright, R. A. Johnson, B. J.; Schoepp, D. D. J. Med. Chem. 1998, 41, 346;
15. b) Hanessian, S.; Cantin, L.D. Molecules on Line. 1998, 2, 47;
16. c) Ma, D.; Ma, J.; Dai, L. Tetrahedron: Asymmetry 1997, 8, 825;
17. d) Pellicciari, R.; Marinozzi, M.; Natalini, B.; Costantino, G.; Luneia, R.; Giorgi, G.; Moroni, Thonen, C. J. Med. Chem. 1996, 39, 2259;
18. e) Shimamoto, K.; Ohfune, Y. J. Med. Chem. 1996, 36, 407.
19. [6] a) Wermuth, C. G.; Schoenfelder, A.; Wright, R. A. Johnson, B. J.; Burnett, J. P.; Mayne, N. G.; Schoepp, D. D. J. Med. Chem. 1996, 39, 814;
20. b) Gu Z-Q.; Hesson D. P; Pelletier, J. C.; Maccecchini, M. L. J. Med. Chem. 1995, 38, 2518.
21. [7] Hanessian, S.; Margarita, R. preceding paper.
22. [8] a) Hanessian, S; Wang, W.; Gai, Y. Tetrahedron Lett. 1996, 42, 7473:
23. b) Hanessian, S; Wang, W.; Gai, Y. Tetrahedron Lett. 1996, 42, 7477
24. c) Wittenberger, S. J.; Boyd, S. A.; Baker, W. R. Synlett 1993, 795;
25. d) Narasaka, K.; Yutaka, U. Bull. Chem. Soc. Jpn. 1988, 61, 571;
26. e) Narasaka, K.; Ukaji, Y. Chem. Lett. 1986, 81.
27. [9] Hanessian, S; Schaum, R. Tetrahedron Lett., 1997, 38, 163; Possible transition state models: (formula presented)
28. [10] a) Hanessian, S.; Vanasse, B. Can. J. Chem. 1993, 71, 1401;
29. b) Fernandez-Megia, E.; Paz, M. M.; Sardina, F. J. J. Org. Chem. 1994, 59, 7643.
30. [11] Hanessian, S.; Yang, H.; Schaum, R. J. Am. Chem. Soc. 1996, 118, 2507.
31. [12] Echalier, F.; Constant, O; Bolte, J. J. Org. Chem. 1993, 58, 2747 and reference therein.
32. [13] See for example: a) ref 6b;
33. b) Gu Z-Q.; Hesson D. P. Tetrahedron Lett. 1995, 6, 2101;
34. c) Johnstone, A. N. C.; Lopatriello, S.; North, M. Tetrahedron Lett. 1994, 35, 6335;
35. d) Koskinen, A. M. P.; Rapoport, H. J. Org. Chem. 1989, 54, 1859;
36. e) Baldwin, J. E.; North, M.; Flinn, A.; Moloney, M. G. J. Chem. Soc., Chem. Commun. 1988, 828. See also ref. 10a.
37. [14] a) Oppolzer W.; Thirring, K. J. Am. Chem. Soc. 1982, 104, 4978
38. b) Spencer, J. R.; Antonenko, V. V.; Delaet, N. G. J.; Goodman, M. Int. J. Peptide protein Res., 1992, 40, 282
39. c) Adams, D. R.; Bailey, P. D.; Collier, I. D.; Heffeman, J. D.; Stokes, S. J. Chem. Soc., Chem. Commun. 1997, 349 and reference therein
40. [15] Typical procedure: a solution of substrate (1 mmol) was dissolved in dry THF (4 ml) and added dropwise (via cannula) to a stirring solution of LiHMDS (2.1 mmol, Aldrich 1M in THF). After about 30 min. freshly distilled allyl iodide or bromide (3 mmol, neat) was added and the reaction mixture was stirred at -78°C until disappearance of the starting material. Quenching with 10% HCl (-78°C), work-up and silica gel flash chromatography (hexanes/AcOEt) provided the desired alkylated compound.
41. [16] a. Charrier, J.-D.; Duffy, J. E. S.; Hitchcock, P. B.; Young, D. W. Tetrahedron Lett. 1998, 39, 2199;
42. b. Ezquerra, J.; Pedregal, C.; Rubio, A.; Yruretagoyena, B.; Escribano, A.; Sanchez-Ferrando, F.; Carreno, M. C.; Ruano, J. L. G. J. Org. Chem 1995, 60, 295.
43. [17] a) Ezquerra, J.; Pedregal, C.; Rubio, A.; Yruretagoyena, B.; Escribano, A.; Sanchez-Ferrando, F. Tetrahedron 1993, 49, 8665;
44. b) Dickshit, D. K.; Panday, S. K. J. Org. Chem 1990, 57, 1920; see also ref. 16a.
45. [18] For recent examples of 4-substituted pipecolic acid see for example: a) Jackson, R. F. W.; Turner, D.; Block, M. H. Synlett, 1997, 789;
46. b) Agami, C.; Bihan, D.; Morgentin, R.; Puchot-Kadouri, C. Synlett, 1997, 799;
47. c) Herdis, C.; Heller, E.; Tetrahedron: Asymmetry, 1997, 8, 1115;
48. d) Skiles, J. W.; Giannousis, P. P.; Fales, K. R. Bioorg. & Med. Chem. Lett. 1996 6, 963;
49. Bailey, P. D.; Londesbrough, D. J.; Hancox, T. C.; Heffeman, J. D.; Holmes, A. B. J. Chem. Soc., Chem. Commun. 1994, 2543 and reference therein.
50. [19] Cossy, J.; Cases, M.; Pardo, C. D. Synth. Commun. 1997, 27, 2769.
51. [20] a) Shimamoto, K.; Ishida, M.; Shinozaki, H. Ohfune, Y. J. Org. Chem. 1991, 56, 4167
52. b) Watkins, J. C. Krogsgaard-Larsen, P.; Honore, T. Trends Pharmacol. Sci. 1990, 11, 25;
53. c) Monaghan, D.T.; Bridges, R. J.; Cotman, C. W. Annu. Rev. Pharmacol. Toxicol. 1989, 29, 365 and references therein.